Guest guest Posted November 8, 2008 Report Share Posted November 8, 2008 A Massachusetts-based health care firm and the U.S. Food and Drug Administration issued a nationwide recall on Thursday for nearly half a million disposable hypodermic insulin syringes due to a mislabeling error that could give patients as much as 2.5 times the intended dose. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.